PIPA5144011

Nova-2 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5144011-Each-of-1 In Stock ₹ 35,422.00

PIPA5144011 - Each of 1

₹ 35,422.00

In Stock

Quantity

1

Base Price: ₹ 35,422.00

GST (18%): ₹ 6,375.96

Total Price: ₹ 41,797.96

Antigen

Nova-2

Classification

Polyclonal

Conjugate

Unconjugated

Gene

NOVA2

Gene Alias

ANOVA; astrocytic NOVA1-like RNA-binding protein; Gm1424; neuro-oncological ventral antigen 2; neuro-oncological ventral antigen 3; NOVA alternative splicing regulator 2; NOVA2; NOVA3; RNA-binding protein Nova-2

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

292681, 384569, 4858

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Isotype

IgG

Applications

ELISA, Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot

Concentration

500 μg/mL

Formulation

PBS with 4MG trehalose and 0.05MG sodium azide

Gene Accession No.

Q9UNW9

Gene Symbols

NOVA2

Immunogen

E.coli-derived human NOVA2 recombinant protein (Position: M1-Q205).

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human, Mouse, Rat

Form

Lyophilized

Related Products

Img

Thermo Scientific

PIPA530516

--

Img

Thermo Scientific

PIPA530544

--

Img

Thermo Scientific

PIPA530931

--

Img

Thermo Scientific

PIPA530887

--

Img

Thermo Scientific

PIPA530397

--

Img

Thermo Scientific

PIPA530700

--

Img

Thermo Scientific

PIPA531166

--

Img

Thermo Scientific

PIPA554414

--

Description

  • Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL
  • Paraneoplastic opsoclonus myoclonus ataxia (POMA) is a neurologic disorder thought to be mediated by an autoimmune attack against onconeural disease antigens that are expressed by gynecologic or lung tumors and by neurons
  • Nova-1 and -2 are both POMA disease antigens
  • The autoimmune attack against Nova-2 in POMA patients results in latent cancer, reduced inhibitory control of movements, and dementia
  • Nova-2 is closely related to Nova-1, and is expressed at high levels in neurons during development and at lower levels in the adult lung
  • In the postnatal mouse brain, Nova-2 is expressed in a pattern that is largely reciprocal with Nova-1, including high levels of Nova-2 expression in the neocortex and hippocampus
  • Both Novas are RNA binding proteins, and Nova-2 binds RNA with high affinity and with sequence specificity that differs from Nova-1
  • They regulate neuronal pre-messenger RNA splicing by directly binding to RNA
  • Nova-2 target genes function either in the synapse or in axon guidance indicating that Nova-2 is a major regulator of synaptic function.